PDA

View Full Version : Early Registration deadline: Engineers and Surgeons: Joined atthe Hip conference 19-21 April, London.



mtaylor75
01-31-2007, 02:27 AM
Engineers and Surgeons: Joined at the Hip
19-21 April 2007
One Great George Street, London, UK

Full programme details can be found at: www.imeche.org.uk/events/hip

Early Registration deadline: 28th February 2007

This conference will bring together surgeons and engineers to discuss
the current issues related to the future development of hip
arthroplasty.

It is well-accepted that conventional hip replacement performs well in
the elderly patient, with survivorship rates in excess of 90% at 10
years. However, the current challenge is to find a viable alternative
for the young active person. Some would argue that the latest generation
of conventional hip replacements, using hard on hard articulations and
either modern cementing techniques or cementless fixation systems, are
suitable for the younger patient. However, many would argue that they
are not suitable and this has lead to the resurgence in the use of hip
resurfacing over the past five years. Although the short to mid-term
results look encouraging, there is still significant debate around the
optimal design of the bearing, choice of fixation method and appropriate
patient selection criteria.

There have also been significant advances in surgical technique over the
past 5 years, with adoption of navigation, robotic and computer assisted
surgery (CAS), as well as the development of minimally invasive
approaches. There are certainly questions about whether CAS has a
measurable impact on the performance of hip replacement, either in terms
of improved function or longevity. Minimally invasive surgery may offer
some advantages, such as quicker rehabilitation times, but the lack of
access may lead to mal-orientation of the components and the associated
increased risk in failure. So, how can we improve minimally invasive
surgery and is the development of smaller implants, e.g. short stemmed
femoral components, the way forward?

The number of revision procedures is increasing, so what happens when it
all goes wrong and the implant needs revising? As a community, do we
devote sufficient research effort to revision surgery as opposed to
primary hip arthroplasty?

One of the reasons for so many unanswered questions is that we still do
not possess the necessary tools to evaluate adequately the performance
of hip replacements in vitro or in vivo. The vast majority of
pre-clinical testing is comparative rather than predictive. What are
the challenges that need to be addressed in order to develop truly
predictive pre-clinical tests? What technologies and techniques are
available to give us greater insight into the in vivo behaviour of hip
replacement?


Conference Enquiries
Alison Payton
Institution of Mechanical Engineers
1 Birdcage Walk
London SW1H 9JJ, UK
Tel: 00 44 (0)20 7304 6829
Fax: 00 44 (0)20 7222 9881
Email: a_payton@imeche.org.uk
www.imeche.org.uk/events/hip
Kind regards,

Mark

IMechE Engineers and Surgeons: Joined at the Hip Conference
London, 19-21 April 2007
www.imeche.org.uk/events/hip

Prof. Mark Taylor
Professor of Bioengineering Science

Bioengineering Science Research Group
School of Engineering Science
University of Southampton
Highfield
Southampton
SO17 1BJ

Tel: ++ 44 (0)2380 597660
Fax: ++ 44 (0)2380 593016
Mobile: ++ 44 (0)7939 101019